Moritz Maas

544 total citations · 1 hit paper
27 papers, 344 citations indexed

About

Moritz Maas is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Moritz Maas has authored 27 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 12 papers in Surgery and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Moritz Maas's work include Bladder and Urothelial Cancer Treatments (12 papers), Urinary and Genital Oncology Studies (10 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Moritz Maas is often cited by papers focused on Bladder and Urothelial Cancer Treatments (12 papers), Urinary and Genital Oncology Studies (10 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Moritz Maas collaborates with scholars based in Germany, Austria and Canada. Moritz Maas's co-authors include Tilman Todenhöfer, Arnulf Stenzl, Jens Bedke, Peter C. Black, Viktoria Stühler, Steffen Rausch, Simon Walz, Jörg Hennenlotter, Miriam Hegemann and Geerard L. Beets and has published in prestigious journals such as International Journal of Molecular Sciences, Annals of Oncology and Cells.

In The Last Decade

Moritz Maas

27 papers receiving 342 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Urine biomarkers in bladder cancer — current status and future perspectives

2023 66 citations Moritz Maas, Tilman Todenhöfer et al. Nature Reviews Urology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Moritz Maas Germany	12	144	139	104	101	72	27	344
Viktoria Stühler Germany	12	96 0.7×	71 0.5×	139 1.3×	157 1.6×	76 1.1×	34	308
Shota Fujimoto Japan	10	147 1.0×	67 0.5×	96 0.9×	132 1.3×	48 0.7×	27	309
Koichiro Ogihara Japan	10	109 0.8×	206 1.5×	68 0.7×	72 0.7×	52 0.7×	27	311
Ursula Kühs Germany	11	130 0.9×	111 0.8×	143 1.4×	112 1.1×	126 1.8×	27	335
Alberto Carretero-González Spain	9	195 1.4×	62 0.4×	83 0.8×	123 1.2×	75 1.0×	20	310
Alessandra Modena Italy	11	147 1.0×	59 0.4×	148 1.4×	183 1.8×	114 1.6×	29	368
Nayneeta Deshmukh United Kingdom	8	93 0.6×	129 0.9×	94 0.9×	133 1.3×	84 1.2×	13	319
Junyao Xu China	10	86 0.6×	45 0.3×	185 1.8×	54 0.5×	72 1.0×	27	325
Travis Rice‐Stitt United States	9	81 0.6×	101 0.7×	91 0.9×	71 0.7×	73 1.0×	15	296

Countries citing papers authored by Moritz Maas

Since Specialization

Citations

This map shows the geographic impact of Moritz Maas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moritz Maas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moritz Maas more than expected).

Fields of papers citing papers by Moritz Maas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moritz Maas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moritz Maas. The network helps show where Moritz Maas may publish in the future.

Co-authorship network of co-authors of Moritz Maas

This figure shows the co-authorship network connecting the top 25 collaborators of Moritz Maas. A scholar is included among the top collaborators of Moritz Maas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moritz Maas. Moritz Maas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Maas, Moritz, Viktoria Stühler, Simon Walz, et al.. (2024). PD-L1 Expression in High-Risk Non-Muscle-Invasive Bladder Cancer Is Influenced by Intravesical Bacillus Calmette–Guérin (BCG) Therapy. Cancers. 16(7). 1356–1356. 5 indexed citations

Tully, Karl H., Moritz Maas, Peter B. Bach, et al.. (2024). An Empirical Survey on the Adaption of Neoadjuvant Chemotherapy in Bladder Cancer. Urologia Internationalis. 108(3). 183–189. 1 indexed citations

Maas, Moritz, Jörg Hennenlotter, Marcus Scharpf, et al.. (2023). Differential Expression and Clinical Relevance of C-X-C Motif Chemokine Receptor 4 (CXCR4) in Renal Cell Carcinomas, Benign Renal Tumors, and Metastases. International Journal of Molecular Sciences. 24(6). 5227–5227. 2 indexed citations

Maas, Moritz, Tilman Todenhöfer, & Peter C. Black. (2023). Urine biomarkers in bladder cancer — current status and future perspectives. Nature Reviews Urology. 20(10). 597–614. 66 indexed citations breakdown →

Maas, Moritz, et al.. (2023). A Peritoneal Purse-String Suture Prevents Symptomatic Lymphoceles in Retzius-Sparing Robot-Assisted Radical Prostatectomy. Journal of Clinical Medicine. 12(3). 791–791. 4 indexed citations

Walz, Simon, Johannes Schneider, Moritz Maas, et al.. (2023). A Protocol for Organoids from the Urine of Bladder Cancer Patients. Cells. 12(17). 2188–2188. 14 indexed citations

Stühler, Viktoria, Moritz Maas, Simon Walz, et al.. (2022). Prognostic impact of complete metastasectomy in metastatic renal cell carcinoma in the era of immuno-oncology-based combination therapies. World Journal of Urology. 40(5). 1175–1183. 12 indexed citations

Walz, Simon, Qingqing Wang, Xinjie Zhao, et al.. (2021). Comparison of the metabolome in urine prior and eight weeks after radical prostatectomy uncovers pathologic and molecular features of prostate cancer. Journal of Pharmaceutical and Biomedical Analysis. 205. 114288–114288. 3 indexed citations

Todenhöfer, Tilman, et al.. (2021). Retrospective German claims data study on initial treatment of bladder carcinoma (BCa) by transurethral bladder resection (TURB): a comparative analysis of costs using standard white light- (WL-) vs. blue light- (BL-) TURB. World Journal of Urology. 39(8). 2953–2960. 6 indexed citations

10.

Maas, Moritz, Johannes Mischinger, Éva Compérat, et al.. (2021). Utility of pT3 substaging in lymph node-negative urothelial carcinoma of the bladder: do pathologic parameters add to prognostic sub-stratification?. World Journal of Urology. 39(11). 4021–4027. 1 indexed citations

11.

Maas, Moritz, Jörg Hennenlotter, Viktoria Stühler, et al.. (2020). Prognostic impact of somatostatin receptor expression in advanced bladder cancer. Urologic Oncology Seminars and Original Investigations. 38(12). 935.e17–935.e28. 3 indexed citations

12.

Walz, Simon, Moritz Maas, Arnulf Stenzl, & Tilman Todenhöfer. (2019). Bone Health Issues in Patients with Prostate Cancer: An Evidence-Based Review. The World Journal of Men s Health. 38(2). 151–151. 6 indexed citations

13.

Stenzl, Arnulf, et al.. (2019). Circulating tumor cells and their role in prostate cancer. Asian Journal of Andrology. 21(1). 24–24. 16 indexed citations

14.

Chalabi, Myriam, Lorenzo F. Fanchi, Geerard L. Beets, et al.. (2018). Neoadjuvant ipilimumab plus nivolumab in early stage colon cancer. Annals of Oncology. 29. viii731–viii731. 46 indexed citations

15.

Stühler, Viktoria, et al.. (2018). Molecular predictors of response to PD-1/PD-L1 inhibition in urothelial cancer. World Journal of Urology. 37(9). 1773–1784. 15 indexed citations

16.

Maas, Moritz, Jens Bedke, Arnulf Stenzl, & Tilman Todenhöfer. (2018). Can urinary biomarkers replace cystoscopy?. World Journal of Urology. 37(9). 1741–1749. 28 indexed citations

17.

Bier, Simone, Jörg Hennenlotter, Michael Esser, et al.. (2018). Performance of Urinary Markers for Detection of Upper Tract Urothelial Carcinoma: Is Upper Tract Urine More Accurate than Urine from the Bladder?. Disease Markers. 2018. 1–5. 13 indexed citations

18.

Maas, Moritz, Simon Walz, Viktoria Stühler, et al.. (2018). Molecular markers in disease detection and follow-up of patients with non-muscle invasive bladder cancer. Expert Review of Molecular Diagnostics. 18(5). 443–455. 8 indexed citations

19.

Stenzl, Arnulf, Miriam Hegemann, Moritz Maas, et al.. (2017). Current concepts and trends in the treatment of bone metastases in patients with advanced prostate cancer. Asian Journal of Andrology. 21(1). 12–12. 7 indexed citations

20.

Schlager, Daniel, Moritz Maas, Simon Hein, et al.. (2016). Flexible Vesiculovasoscopy Using a Microoptical System in a Human Cadaver Model: An Experimental Approach for Atraumatic Endoscopy of the Seminal Tract. Journal of Endourology. 30(8). 934–938. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact